Trial intelligence / Profile preview

Nicotine patch versus placebo for selective attention in healthy volunteers

ACTRN12609000511235Phase 4Not yet recruiting

Sponsor
Associate Professor Mark Bellgrove
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of nicotine in None (2 arms), sponsored by Associate Professor Mark Bellgrove. Primary endpoints: Eriksen Flanker Task performance and Covert Visual Orienting Task performance. Planned start Jun 2009; status: not yet recruiting.

02

Drugs

nicotine

Beyond the preview

Go deeper on ACTRN12609000511235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12609000511235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call